| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000031487 |
| Receipt No. | R000035945 |
| Official scientific title of the study | Test of the effect of zinc intake on changes of zinc concentration in the semen |
| Date of disclosure of the study information | 2018/02/26 |
| Last modified on | 2018/03/27 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Test of the effect of zinc intake on changes of zinc concentration in the semen | |
| Title of the study (Brief title) | Test of the effect of zinc intake on changes of zinc concentration in the semen | |
| Region |
|
|
| Condition | ||
| Condition | Healthy Adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To elucidate the amount of change by zinc intake in zinc concentration quantitatively measured in the semen. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Intestinal bacterial flora at the beginning of the test, after ingestion of two weeks, and after ingestion of four weeks |
| Key secondary outcomes | Semen test (ejaculate size, sperm concentration, total sperm number, leukocyte number, malformation rate of sperm, testosterone, creatine, polyamine, 8-OHdG, BDNF, oxytocin, total protein amount, fatty acid, organic acid, amino acid, carbohydrate, cholesterol, HPV etc.) at the beginning of the test, after ingestion of two weeks, and after ingestion of four weeks and questionnaire |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Ingest total 30 mg of zinc per day | |
| Interventions/Control_2 | None | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1. Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2. Healthy Japanese men who are 20 years old or more |
|||
| Key exclusion criteria | 1. Persons who have a chronic disease and is under medication, or has a serious disease history
2. Persons who are allergic to the test food 3. Persons who are judged inappropriate for the exam by the principal investigator |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Yosuke Takimoto |
| Organization | Dantte Co., Ltd. |
| Division name | Representative director |
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN |
| TEL | 03-6809-2722 |
| takimoto@dantte.jp | |
| Public contact | |
| Name of contact person | Yosuke Takimoto |
| Organization | Dantte Co., Ltd. |
| Division name | Representative director |
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN |
| TEL | 03-6809-2722 |
| Homepage URL | |
| takimoto@dantte.jp | |
| Sponsor | |
| Institute | Dantte Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Dantte Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035945 |